isoquinoline derivative(Harbin Gloria Pharma)

N/A

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug Nameisoquinoline derivative(Harbin Gloria Pharma)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPhosphoglycerate kinase 1 modulators
TargetsPhosphoglycerate kinase 1
Therapy Area/IndicationsNerve DegenerationGlucose Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCapital Medical University
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Gloria Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsNerve DegenerationGlucose Metabolism Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A